1. Dusty Punch Cards and an Eternal Enigma: High-Density Lipoproteins and Atherosclerosis

   • Marcus E. Kleber
   • Tanja B. Grammer
   • Winfried März

   Current Opinion 02 April 2014 Pages: 513 - 520

   

2. Omalizumab for Severe Asthma: Efficacy Beyond the Atopic Patient?

   • Christian Domingo

   Current Opinion 02 April 2014 Pages: 521 - 533

   

3. Omalizumab: Stepping Outside Our Comfort Zone to Broaden the Number of Those Who Can Benefit

   • Mario Cazzola
   • Andrea Segreti

   Commentary 02 April 2014 Pages: 535 - 537

4. Meta-Review: Adverse Effects of Inhaled Corticosteroids Relevant to Older Patients

   • Katharina Mattishent
   • Menaka Thavarajah
   • Yoon K. Loke

   Systematic Review 22 March 2014 Pages: 539 - 547

   

5. Pomalidomide: A Review of Its Use in Patients with Recurrent Multiple Myeloma

   • Lesley J. Scott

   Adis Drug Evaluation 04 March 2014 Pages: 549 - 562

   

6. Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex^®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis

   • Yahiya Y. Syed
   • Kate McKeage
   • Lesley J. Scott

   Adis Drug Evaluation 27 March 2014 Pages: 563 - 578

   

7. Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases

   • Matt Shirley
   • Paul L. McCormack

   Adis Drug Evaluation 08 March 2014 Pages: 579 - 586

   

8. Vildagliptin: A Review of Its Use in Type 2 Diabetes Mellitus

   • Gillian M. Keating

   Adis Drug Evaluation 18 March 2014 Pages: 587 - 610

9. Ipragliflozin: First Global Approval

   • Raewyn M. Poole
   • Rosselle T. Dungo

   R&D Insight Report 26 March 2014 Pages: 611 - 617